Johnson & Johnson Aktie

149,52USD -0,95USD -0,63%
Johnson & Johnson für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 853260 / ISIN: US4781601046
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,88
The Vanguard Group, Inc. 9,53
Vanguard Group, Inc. (Subfiler) 9,15
State Street Corp. 5,58
SSgA Funds Management, Inc. 5,52
Vanguard Total Stock Market ETF 3,16
BlackRock Fund Advisors 3,11
Vanguard 500 Index Fund 2,65
Geode Capital Management LLC 2,33
BlackRock Institutional Trust Co. NA 2,21
State Farm Investment Management Corp. 1,32
Fidelity 500 Index Fund 1,23
Norges Bank (13F) 1,21
iShares Core S&P 500 ETF 1,11
Morgan Stanley Smith Barney LLC 0,98

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 132 200 134 500 141 700 152 700 131 900
Umsatz pro Mitarbeiter in Mio. EUR 0,62 0,61 0,66 0,62 0,65

Bilanz (in Mio. USD) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 45 274 51 237 60 979 55 294 53 495
Summe Anlagevermögen 112 454 123 657 121 039 132 084 114 063
Summe Aktiva 157 728 174 894 182 018 187 378 167 558

Bilanz (in Mio. USD) - Passiva

2019 2020 2021 2022 2023
Summe Fremdkapital 98 257 111 616 107 995 110 574 98 784
Summe Eigenkapital 59 471 63 278 74 023 76 804 68 774
Summe Passiva 157 728 174 894 182 018 187 378 167 558

Adresse

One Johnson & Johnson Plaza, 08933 New Brunswick
Telefon +1 (732) 524-0400
Internet http://www.jnj.com

Management

Anne M. Mulcahy
Independent Director
Caroline Tillett
Global Head-Consumer Health
Darius Adamczyk
Independent Director
Elizabeth Forminard
Executive Vice President & General Counsel
Eugene A. Woods
Independent Director
George Davy
Global HR Director
Hubert Joly
Independent Director
James D. Swanson
Chief Information Officer & Executive VP
Jennifer A. Doudna
Independent Director
Jennifer L. Taubert
EVP & Worldwide Chairman-Innovative Medicine
Jessica Moore
Vice President-Investor Relations
Joaquin Duato
Chairman & Chief Executive Officer
John C. Reed
Executive Vice President-Innovative Medicine
Jonathan Sheh
Director-Workplace Experience
Joseph J. Wolk
Chief Financial Officer & Executive Vice President
Juliana Clawson
Head-Global Quality & Compliance
Kathryn E. Wengel
Chief Technical Operations & Risk Officer
Kristen Blair Mulholland
Chief Human Resources Officer & Executive VP
Lisa Paley
Vice President-US Sales
Marc Larkins
Secretary & Vice President-Governance
Marillyn A. Hewson
Lead Independent Director
Mark Alan Weinberger
Independent Director
Mark B. McClellan
Independent Director
Mary C. Beckerle
Independent Director
Meredith Stevens
Vice President
Michael Bzdak
Global Dir-Employee Engagement-Global Cmnty Impact
Nadja Y. West
Independent Director
Neil Ackerman
Head-Innovation, Global Supply & Transformation
Paul Ruh
Chief Financial Officer-Consumer Health
Paula A. Johnson
Independent Director
Robert J. Decker
Chief Accounting Officer & Controller
Ronald A. Kapusta
Chief Accounting Officer & Controller
Thomas J. Spellman
Secretary
Timothy Schmid
Executive Vice President & Chairman-Worldwide
William E. Cohn
Vice President-Medical Devices
William N. Hait
Chief External Innovation & Executive VP-Medical